Company: CPMV
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001683168-25-002584
Chunk: 314

Company: Mosaic ImmunoEngineering Inc.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 1C
Chunk 314
---
 by our named executive officers as of December 31, 2024:

    Option Awards
     
    Stock Awards
  
    Name

    Grant
    Date

    Number of
    Securities
    Underlying
    Unexercised
    Options (#)
    Exercisable

    Number of
    Securities
    Underlying Unexercised
    Options (#) Unexercisable(1)

    Option
    Exercise
    Price ($)

    Option
    Expiration
    Date
     
    Number of Shares or Units of Stock That Have Not Vested (#)
     
    Market Value of Shares or Units of Stock That Have Not Vested ($)(3)
  
    Steven King
     
    12/16/2020(1)
     
    –
     
    –
     
    –
     
    –
     
    65,218
     
    45,653

    12/16/2020(2)
     
    –
     
    –
     
    –
     
    –
     
    43,479
     
    30,435
  
    Paul Lytle 
     
    12/16/2020(1)
     
    –
     
    –
     
    –
     
    –
     
    42,392
     
    29,674

    12/16/2020(2)
     
    –
     
    –
     
    –
     
    –
     
    37,772
     
    26,440

____________________

(1)RSU award will vest 100% on the sooner of (i) August 31, 2026, provided the Company is listed on a national
exchange such as the Nasdaq Stock Market prior to August 31, 2026 (ii) upon a merger or acquisition of the Company, provided the holder
agrees to accept the underlying shares in writing, or (iii) upon the holders last date of employment, provided the holder agrees to accept
the underlying shares in writing.

(2)RSU award will vest 100% on the sooner of (i) August 31, 2027, provided the Company is listed on a national
exchange such as the Nasdaq Stock Market prior to August 31, 2027 (ii) upon a merger or acquisition of